AUS
NZ
UK
CA
USA
IND
Healthcare
SCOR Q2 Loss Amid Rising Revenues; L&H CEO to Depart
July 30, 2024 05:10 AM PDT| By Team Kalkine MediaHeadlines:,SCOR Reports Q2 Loss Amid Mixed Revenue Growth,P&C Insurance Revenue Sees Notable Increase; L&H Revenue Marginally Declines,L&H CEO Frieder Knupling Steps Down; Thierry Leger Assumes Role,SCOR SE (OTC:SZCRF), a leading French reinsurance p...
Calquence-Venetoclax Combo Shows Promise; Impact on Healthcare Stocks
July 29, 2024 05:19 AM PDT| By Team Kalkine MediaHeadlines:,Amplify Trial Results Show Significant Improvement with Calquence Combination,Trend Favoring Calquence in Overall Survival Observed, Awaiting Further Data,Chronic Lymphocytic Leukemia Cases Expected to Rise Globally,AstraZeneca(NASDAQ:AZN)...
GSK’s Arexvy RSV Vaccine Gains CHMP Approval for Ages 50-59
July 29, 2024 05:14 AM PDT| By Team Kalkine MediaHeadlines:,GSK’s Arexvy RSV Vaccine Receives Positive CHMP Opinion for Adults Aged 50-59 at Higher Risk,Expansion of Arexvy Approval Could Include Adults Aged 50-59 by September 2024,GSK’s RSV Vaccine Trials Progress in Multiple Regions, Including th...
Merck's Q2 2024 Earnings Preview: Key Trends and Future Prospects
July 29, 2024 04:57 AM PDT| By Team Kalkine MediaHeadlines:,Q2 2024 Revenue and Earnings Expectations,Stock Performance and Market Trends Analysis,Valuation Insights and Future Outlook,Merck (NYSE:MRK) is scheduled to unveil its Q2 2024 financial results on Tuesday, July 30. Anticipations are set f...
Pfizer's Q2 2024 Outlook: Revenue Projections and Market Performance
July 29, 2024 04:52 AM PDT| By Team Kalkine MediaHeadlines:,Pfizer's Q2 Report and Revenue Expectations,Historical Stock Performance and Market Trends,Valuation Insights and Future Predictions,Pfizer (NYSE:PFE) is set to disclose its Q2 2024 financial results on Tuesday, July 30. Analysts anticipat...
Bausch Health Addresses Bankruptcy Speculation, Affirms No Plans for Filing
July 25, 2024 10:27 AM PDT| By Team Kalkine MediaHeadlines:,Bausch Health responds to bankruptcy,rumors,, clarifying that it is not contemplating bankruptcy.,The company emphasizes its commitment to,maintaining,financial stability and addressing market concerns.,Bausch Health aims to reassure stake...
HCA Healthcare Stock Soars as Company Exceeds Expectations and Upgrades Revenue Forecast
July 24, 2024 12:00 AM PDT| By Team Kalkine MediaSummary:,- HCA Healthcare's stock increased by over 5% on Tuesday.,- The company's performance exceeded expectations.,- HCA Healthcare raised its full-year forecast.,- Net income rose to $1.46 billion, with earnings per share reaching $5.53.,- Sales...
Novartis (SWX: NOVN) Reports Robust Q2 Growth, Raises FY 2024 Guidance
July 18, 2024 11:07 PM PDT| By Team Kalkine MediaNovartis (SWX: NOVN) has delivered strong financial results in the second quarter of 2024, leading to a raised full-year bottom-line guidance. The company achieved notable increases in net sales and core operating income, highlighting the success of...
GE HealthCare (Nasdaq: GEHC) Expands AI Capabilities with Intelligent Ultrasound Acquisition
July 18, 2024 01:47 AM PDT| By Team Kalkine MediaGE Healthcare (Nasdaq: GEHC) has announced a strategic acquisition aimed at bolstering its capabilities in clinical artificial intelligence (AI) software. The agreement involves acquiring Intelligent Ultrasound Group PLC’s (Intelligent Ultrasound) AI...
UnitedHealth Group (NYSE: UNH) Reports Strong Second Quarter 2024 Results Amid Growth and Challenges
July 16, 2024 10:05 PM PDT| By Team Kalkine MediaUnitedHealth Group (,NYSE: UNH,) has announced its second quarter 2024 financial results, demonstrating robust performance driven by significant growth across its Optum and UnitedHealthcare segments. The company reported revenues totalling $98.9 bill...
Mainz Biomed N.V. (NASDAQ: MYNZ), Pursues Breakthrough Device Designation for Next-Generation Colorectal Cancer Test
July 09, 2024 02:01 AM PDT| By Team Kalkine MediaMainz Biomed N.V. (,NASDAQ: MYNZ,), a frontrunner in molecular genetics diagnostics with a focus on early cancer detection, has reached a pivotal milestone by submitting an application to the U.S. Food and Drug Administration (FDA) for Breakthrough D...
GSK’s (LSE/NYSE: GSK) Omjjara Approved in Japan for Myelofibrosis Treatment
June 27, 2024 02:24 AM PDT| By Team Kalkine MediaGSK plc (LSE/,NYSE: GSK,) has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Omjjara (momelotinib) for the treatment of myelofibrosis. Omjjara is a once-daily, oral inhibitor of JAK1/JAK2 and activin A receptor type...
Evotec (NASDAQ: EVO) and Bristol Myers Squibb: Advancing Neuroscience Innovation
June 12, 2024 01:12 AM PDT| By Team Kalkine MediaEvotec SE (,NASDAQ: EVO,) has announced a significant leap forward in its neuroscience collaboration with Bristol Myers Squibb (,NYSE: BMY,), marking a milestone achievement in the quest for novel treatments for neurodegenerative diseases. The latest...
Belite Bio's (NASDAQ: BLTE) Tinlarebant Granted Sakigake Designation for STGD1 Treatment
June 12, 2024 01:06 AM PDT| By Team Kalkine MediaBelite Bio, Inc (,NASDAQ: BLTE,), a distinguished player in the realm of clinical-stage biopharmaceutical drug development, has achieved a significant milestone with its lead pipeline candidate, Tinlarebant. The company proudly announces that Tinlare...
Alvotech (NASDAQ: ALVO) and STADA Forge Strategic Alliance to Expand Access to Biosimilars
June 11, 2024 01:29 AM PDT| By Team Kalkine MediaAlvotech (,NASDAQ: ALVO,) and STADA, two prominent players in the pharmaceutical industry, have announced the extension of their strategic alliance, aiming to bolster access to high-quality and cost-effective biosimilars. The latest development sees...
111, Inc. (NASDAQ: YI) and Scrianen Forge Strategic Partnership to Revolutionize Healthcare Distribution in China
June 11, 2024 01:24 AM PDT| By Team Kalkine MediaIn a significant move set to reshape the landscape of healthcare distribution in China, 111, Inc. (,NASDAQ: YI,) and Beijing Scrianen Pharmaceutical Co., Ltd. (Scrianen) have joined forces in a strategic direct supply partnership. The announcement, m...
Medtronic (NYSE: MDT) Reports Strong Q4 and FY24 Financial Results, Issues FY25 Guidance
May 23, 2024 03:19 PM PDT| By Team Kalkine MediaMedtronic plc (,NYSE: MDT,) today released its financial results for the fourth quarter (Q4) and fiscal year 2024 (FY24), which ended on April 26, 2024. The company reported steady growth, increased shareholder returns, and provided guidance for FY25...
Regeneron's (NASDAQ: REGN) Q1 financial performance fell short to meet EPS and revenue forecasts
May 02, 2024 11:03 PM PDT| By Team Kalkine MediaHighlights,Regeneron’s Q1 earnings fell short of projections, with lower-than-expected EPS and revenue.,The company’s overall revenues dipped by 1% to US$3.15 billion compared to the same period in 2023.,In April 2024, Regeneron made strategic moves...
UnitedHealth Group (NYSE: UNH) Reports Strong First Quarter 2024 Performance Amid Cyberattack Challenges
April 16, 2024 10:56 PM PDT| By Team Kalkine MediaUnitedHealth Group (,NYSE: UNH,), a prominent player in the healthcare and well-being sector, disclosed its first quarter 2024 earnings report on April 16, 2024. The company, listed on the New York Stock Exchange under the ticker symbol UNH, operates...
Roche's Breakthrough Blood Test for Alzheimer's Receives FDA Designation
April 11, 2024 02:27 PM PDT| By Team Kalkine MediaRoche (SIX: RO, ROG; OTCQX:,RHHBY,), with over 20 years of dedicated scientific research in Alzheimer's disease, is committed to advancing detection methods and treatments to combat this debilitating condition. With a vision of early detection and ha...
